# Fineotex Chemical share price today (Fineotex Chemical Ltd, NSE: FCL)

> Fineotex Chemical share price today: ₹53.42 at the NSE close on 4 November 2026, up 102.7% in a year. Fineotex Chemical (NSE: FCL) is worth ₹6,219 crore, trades at a P/E of 50.9 and has closed between ₹20.17 and ₹60.53 over the past 52 weeks. > Fineotex Chemical Ltd's share price has risen faster than its earnings: +102.7% in a year, against −1.1% for earnings per share. FCL · Speciality Chemicals · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/fineotex-chemical-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹53.42 (+102.7% in a year)
- P/E: 50.9× (higher than 97% of the last 11 years)
- Revenue (Jun 2026): ₹377 Cr (+175.2% on a year ago)
- Profit (Jun 2026): ₹48.0 Cr (+92.0% on a year ago)
- Operating margin: 16.0% (−2.0 points on a year ago)
- ROCE: 18%, FY26
- ROIC: 13.9%, against a 12.0% cost of capital: +1.9 points

The main question: profits are rising, but only 40% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Fineotex Chemical share price today? Fineotex Chemical Ltd's share price was ₹53.42 at the close on 4 November 2026. It has been rising for 23 weeks. That is 32.0% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹20 and ₹61, and at that close it sat 82% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row. Over the last 11 years the share price moved +2,098% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Fineotex Chemical this quarter? Three changes stood out: highest quarterly profit in 15 quarters, highest quarterly revenue in 15 quarters and number of shareholders up 49% in a year. 1. Highest quarterly profit in 15 quarters Profit of ₹48 crore in the June 2026 quarter is the highest of the last 15 quarters. Why: Profit hit a record because the oilfield chemicals business kept more of each sale after cutting operating costs and tightening finance control. From the earnings call on 28 Sep 2026. 2. Highest quarterly revenue in 15 quarters Revenue of ₹377 crore in the June 2026 quarter is the highest of the last 15 quarters. Why: Revenue hit a record because the oilfield chemicals business CCT sold more to existing clients and added new products. From the earnings call on 28 Sep 2026. 3. Number of shareholders up 49% in a year 2,18,792 shareholders in the September 2026 quarter, against 1,46,522 a year earlier. ## What are Fineotex Chemical's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Fineotex Chemical reported revenue of ₹377 crore, up 175.2% from ₹137 crore a year earlier, and a profit of ₹48.0 crore, up 92.0% from ₹25.0 crore. ### Fineotex Chemical results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹377 crore | ₹137 crore | +175.2% |
| Profit | ₹48.0 crore | ₹25.0 crore | +92.0% |
| Earnings per share | ₹0.33 | ₹0.22 | +50.0% |
| Operating margin | 16.0% | 18.0% | −2.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Fineotex Chemical's management discussed these results on a call held on 28 September 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Fineotex Chemical share price history? Fineotex Chemical closed at ₹53.42 on 4 November 2026, up 102.7% from ₹26.36 a year earlier (7 November 2025) and up 318.3% over five years. Its highest weekly close since March 2016 was ₹60.53 on 25 September 2026. ### Fineotex Chemical share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹48.59 | +9.9% |
| 1 month ago · 1 Oct 2026 | ₹55.75 | −4.2% |
| 6 months ago · 8 May 2026 | ₹28.15 | +89.8% |
| 1 year ago · 7 Nov 2025 | ₹26.36 | +102.7% |
| 3 years ago · 3 Nov 2023 | ₹29.63 | +80.3% |
| 5 years ago · 4 Nov 2021 | ₹12.77 | +318.3% |
| 10 years ago · 4 Nov 2016 | ₹3.45 | +1,448.4% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹2.43 | +2,098.4% |
| Highest weekly close since March 2016, also the 52-week high · 25 Sep 2026 | ₹60.53 | −11.7% |
| Lowest weekly close since March 2016 · 27 Mar 2020 | ₹1.50 | +3,461.3% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹20.17 | +164.8% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (564 weekly closes from 11 March 2016 to 4 November 2026.)

## What is the latest news on Fineotex Chemical? 4 Nov 2026: Fineotex Chemical closed at ₹53.42, up 9.9% on the week and down 4.2% on the month. 28 Sep 2026: Fineotex Chemical held its results call for April to June 2026. Management guided: CCT revenue of $200 million by FY2028 remains on track; capacity utilization expected around 75% next year. ### Earlier

- 4 Sep 2026: ex-date for a dividend of ₹0.05 a share. - Results for April to June 2026: Revenue up 175.2% and profit up 92.0% on a year earlier. - 31 Oct 2025: Share split: face value cut from ₹2 to ₹1 a share (ex-date). - 31 Oct 2025: Bonus issue: 4 new shares for every 1 held (ex-date). ## What dividend does Fineotex Chemical pay? Fineotex Chemical paid ₹0.05 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.09% at the ₹53.42 close on 4 November 2026. The last was a dividend of ₹0.05 a share, ex-date 4 September 2026. ### Fineotex Chemical dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 4 Sep 2026 | ₹0.05 | Dividend | same day |
| 3 Oct 2025 | ₹0.80 | Interim | same day |
| 12 Sep 2025 | ₹0.40 | Dividend | 13 Sep 2025 |
| 18 Feb 2025 | ₹0.40 | Interim | same day |
| 3 Sep 2024 | ₹0.40 | Dividend | same day |
| 26 Feb 2024 | ₹1.20 | Interim | same day |
| 8 Sep 2023 | ₹0.80 | Dividend | same day |
| 28 Jul 2022 | ₹0.40 | Dividend | n/a |
| 8 Jul 2021 | ₹0.30 | Dividend | 9 Jul 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Fineotex Chemical Ltd paid out 48% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Fineotex Chemical management say on the latest results call? On the call for April to June 2026, held on 28 September 2026, Fineotex Chemical's management guided: CCT revenue of $200 million by FY2028 remains on track; capacity utilization expected around 75% next year. > “At the blended level, we currently expect overall EBITDA margins of 14-15%”
> Yusuf Contractor, on the call for April to June 2026

### What management guided

- CCT operating margin maintained at 13-15% going forward. - Textile and hygiene operating margin maintained above 20%. - Specialty chemicals and hygiene to remain no more than 30% of portfolio as oil and gas and water treatment expand. - Domestic textile volumes to grow over the next few quarters as trade developments support demand. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/5856-28-Sep-2026.pdf). (From the call for April to June 2026, 28 September 2026.)

## What to watch in Fineotex Chemical's next results? When Fineotex Chemical reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: CCT utilization and volumes moving toward the next-year goal, with overnight client servicing translating into order growth. - What to check (from the call)
- CCT utilization and volumes moving toward the next-year goal, with overnight client servicing translating into order growth. - Consolidated operating margin staying within the guided range as R&D, staffing and client-acquisition costs scale. - AquaStrike remaining production approvals and tendering requirements, plus the first domestic commercialization update. - Domestic textile volumes sustaining the recent improvement as trade developments translate into customer orders. ## Which stock lists is Fineotex Chemical on? Fineotex Chemical is on one of our India lists: Penny stocks. [Penny stocks Earnings growth, 12 months (%): 16.48](https://www.sectoralpha.in/penny-stocks-india)

## Is Fineotex Chemical profitable? Fineotex Chemical Ltd earned ₹48.0 Cr of net profit in the Jun 2026 quarter, +92.0% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹125 Cr. Over 10 years profit has grown 20.1% a year on average. That is 12.7% of the quarter's revenue. The same quarter a year earlier earned ₹25.0 Cr. For the full year, FY26 profit was ₹125 Cr (+14.7% on the year before). Why profit moved: revenue changed +175.2% on a year earlier and the margin moved −2.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +50.1% and revenue +94.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Fineotex Chemical make, and is it growing? Fineotex Chemical Ltd reported ₹377 Cr of revenue in the Jun 2026 quarter, +175.2% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 21.5% a year on average. The last full year, FY26, came in at ₹772 Cr. The last four reported quarters add to ₹1,013 Cr. FY26 revenue was ₹772 Cr, +44.8% on the year before. Recent pace: the last four quarters grew +94.3% on average, against 21.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +91.5%, against +32.4% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +41.0%, against +9.7% a year (accelerating). ## How much of every ₹100 of sales does Fineotex Chemical keep? Fineotex Chemical Ltd's operating margin was 16.0% in the Jun 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 11.0% and 26.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −2.7 percentage points on the year while gross margin changed +1.9 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Fineotex Chemical's profit turning into cash? Over the last 3 years, 40% of Fineotex Chemical Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 its operations used ₹24.0 Cr of cash, against ₹125 Cr of profit. After ₹93.0 Cr of spending on assets, free cash was −₹117 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 40% of profit came in as cash: the cash cycle got 17 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 17 days longer. The next section looks at where the cash is stuck. ## Where does Fineotex Chemical's cash go? Fineotex Chemical Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 133 days in FY26, up from 116 days in FY21. It spent ₹209 Cr on assets over the last 3 years. Customers take 137 days to pay, and stock sits for 112 days on average. At FY26 sales of ₹772 Cr, each day of that cycle ties up about ₹2.1 Cr, so roughly ₹281 Cr is tied up in the business at any time. FY26: customers took 137 days to pay and stock sat for 112 days, about 3.7 months of sales sitting as stock, for a full cycle of 133 days, longer than FY21's 116. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 112 days. Customers pay about 137 days after that. Suppliers are paid at 117 days. Together that makes the 133-day cycle. Spending on assets: ₹209 Cr over the last 3 years, against ₹28.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹2.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Fineotex Chemical's P/E ratio, and how does it compare with its own history? Fineotex Chemical Ltd's P/E is 50.9×, near the high end of its own history: higher than 97% of past readings. Its usual P/E (the middle reading) is 25.9×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −1.1% while the price moved +102.7%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +33.1% a year; about +21.3% a year came from earnings growth and about +11.8 percentage points from the multiple (the market paying more); over 10 years the price moved +31.5% a year; about +18.6% a year came from earnings growth and about +12.9 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Fineotex Chemical business getting better or worse? Fineotex Chemical Ltd's business is turning around. Profit growth has swung from −15.1% at its low to +41.0%, improving for 2 quarters in a row, with ROCE rising at 22.0%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## How much does Fineotex Chemical earn on its capital? Fineotex Chemical Ltd earned a ROCE of 18% in FY26. That is up from a low of 15% in FY14. Its return on capital used (ROIC) is 1.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 16.2% net margin and 0.67× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 16.2% net margin × 0.67× asset turnover × 1.31× leverage (assets divided by equity) ≈ 14.2% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 13.9% − 12.0% = +1.9 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 13.9% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 12.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Fineotex Chemical have too much debt? Fineotex Chemical Ltd has total debt of ₹8.0 Cr against shareholder equity of ₹940 Cr as of Jun 2026, so its debt is 0.01× its equity, which is very little. Year by year, that ratio went from 0.01 in FY22 to 0.01 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Fineotex Chemical shareholding pattern? Domestic institutions cut their stake in Fineotex Chemical Ltd by 2.0 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 1.6% of the company. Foreign institutions moved −1.4 points over the same period, to 2.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −2.0 points over 8 quarters, to 1.6%; Foreign institutions: −1.4 points over 8 quarters, to 2.0%; Promoters: −0.6 points over 8 quarters, to 62.3%. Why the owners changed: domestic institutions drove it (−2.0 points), together with foreign institutions (−1.4 points). They reduced their stake. ## How far is Fineotex Chemical from balance-sheet trouble? For Fineotex Chemical Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Fineotex Chemical rank in its industry? 59.1 out of 100, rank 9 of 30 in Speciality Chemicals, with 96% of the evidence available. Fineotex Chemical Ltd scores 59.1 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 9. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.3 + 13.6 + 5.7 + 19.5 = 59.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Fineotex Chemical compared with? Fineotex Chemical ranks 9 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 59.1 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 82.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 17.6/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 17.6 + 19.7 + 13.9 = 82 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.1/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.1 + 6.6 + 12.5 = 64 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.6 + 10.8 + 10.8 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.3/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.3 + 10 + 10.9 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 59.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.5/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.5 + 11.3 + 11.4 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.7/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.7 + 9.7 + 14.8 = 59.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. Fineotex Chemical Ltd this page FCL · leader · Evidence leans up · 96% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.6 + 5.7 + 19.5 = 59.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.6/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.6 + 16.1 + 7.8 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.1 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.7 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 52.8 out of 100 Growth Capital Valuation Relative
15. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.7 out of 100 Growth Capital Valuation Relative
16. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.6 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 50.9 out of 100 Growth Capital Valuation Relative
18. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
19. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.6 out of 100 Growth Capital Valuation Relative
20. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 45.5 out of 100 Growth Capital Valuation Relative
21. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 45.5 out of 100 Growth Capital Valuation Relative
22. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
23. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 42.3 out of 100 Growth Capital Valuation Relative
26. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.3 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.2 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Fineotex Chemical in size? Fineotex Chemical is the 11th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Clean Science & Technology, Galaxy Surfactants and Neogen Chemicals. Just below it: Yasho Industries, Tatva Chintan Pharma Chem and Vishnu Chemicals. ### Speciality Chemicals companies close in size

1. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) ₹7,606 crore
2. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) ₹7,502 crore
3. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) ₹6,523 crore
4. Fineotex Chemical Ltd ₹5,635 crore
5. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) ₹3,888 crore
6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) ₹3,845 crore
7. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) ₹3,650 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [Cera Sanitaryware Ltd](https://www.sectoralpha.in/stocks/cera-sanitaryware-ltd) ₹5,683 crore · Ceramics/Tiles/Sanitaryware
2. [Rentomojo Ltd](https://www.sectoralpha.in/stocks/rentomojo-ltd) ₹5,645 crore
3. Fineotex Chemical Ltd ₹5,635 crore
4. [Hero Motors Ltd](https://www.sectoralpha.in/stocks/hero-motors-ltd) ₹5,635 crore
5. [JK Lakshmi Cement Ltd](https://www.sectoralpha.in/stocks/jk-lakshmi-cement-ltd) ₹5,634 crore · Cement

## What else do people ask about Fineotex Chemical? ### What is Fineotex Chemical's share price today? Fineotex Chemical Ltd's share price is ₹53.42, +102.7% over the past year. The whole company is worth ₹6,219 Cr on the market. In the last 52 weeks it traded between ₹20 to ₹61; today it is 82% of the way up from the low, 32.0% above its 200-day average (as of 4 November 2026). ### What were Fineotex Chemical's latest quarterly results? Fineotex Chemical Ltd reported revenue of ₹377 Cr and net profit of ₹48.0 Cr for the Jun 2026 quarter. Revenue rose 175.2% and profit rose 92.0% compared with a year earlier. Earnings per share were ₹0.33. The operating margin was 16.0%, 2.0 percentage points lower than a year earlier (as of 4 November 2026). ### What is Fineotex Chemical's market cap? Fineotex Chemical Ltd's market capitalisation is ₹6,219 Cr at a share price of ₹53.42. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Fineotex Chemical performing? Fineotex Chemical Ltd's share price has been rising for 23 weeks. In its latest quarter, revenue rose 175.2% and profit rose 92.0% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 14 weeks running (as of 4 November 2026). ### Will Fineotex Chemical's share price go up? This page does not forecast Fineotex Chemical Ltd's share price. What it shows instead: the share price is ₹53.42, and it has been rising for 23 weeks. Its P/E of 50.9× is higher than 97% of its own last 11 years (as of 4 November 2026). ### Who owns Fineotex Chemical? Promoters own 62.3% of Fineotex Chemical Ltd, foreign institutions 2.0%, domestic institutions 1.6% and the public 34.0% (latest quarter). The biggest change over the last two years: Domestic institutions cut their stake by 2.0 percentage points over 8 quarters (as of 4 November 2026). ### Does Fineotex Chemical have too much debt? No, Fineotex Chemical Ltd has little debt: its debt is 0.01× its equity, and its operating profit is more than 100 times its interest bill. FY26 borrowings were ₹8.0 Cr against equity of ₹882 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is Fineotex Chemical in its business cycle? Fineotex Chemical Ltd's FY26 operating margin was 17.0%, against a 13-year range of 11.0% to 26.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Fineotex Chemical story? The main question: profits are rising, but only 40% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Fineotex Chemical a stock worth studying right now? What the numbers show: Fineotex Chemical Ltd's share price has risen faster than its earnings: +102.7% in a year, against −1.1% for earnings per share. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Fineotex Chemical share price forecast for 2026? What management itself guided: CCT revenue of $200 million by FY2028 remains on track; capacity utilization expected around 75% next year. ## Lists

- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.